Benchmark and TD Cowen reissued buy ratings on Strive shares on June 30, 2026.
6 reports, 2 independent
Updated Aug 17
Gone quiet
- Reports
- 6
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark and TD Cowen reissued buy ratings on Strive shares on June 30, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.TD Cowen dropped its price target on Strive shares while Benchmark reiterated its buy rating.1 source
Benchmark and TD Cowen reissued buy ratings for Strive.1 source
Keep exploring
The entities involved
-
STRIVE
American nonprofit organization
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
-
TD Cowen
American investment bank
Related events
- TD Cowen maintained a Buy rating on Forgent on September 15, 2026.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- Raymond James Financial and TD Cowen issued rating updates for GDS, alongside an insider transaction disclosure filed with the SEC.
- TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.
- TD Cowen, Jefferies, and Citigroup issued updated ratings and target prices for Procore Technologies, Inc.
Coverage
Newest first; wire copies grouped- themarketsdaily.comStrive (ASST) to Announce Earnings on Tuesday
- tickerreport.com